Product Code: GVR-4-68040-550-0
Novel Spectrometry Market Size & Trends:
The novel spectrometry market size was estimated at USD 3,486.0 million in 2024 and is expected to expand at a CAGR of 20.0% from 2025 to 2030. The market is experiencing strong growth, driven by advancements in mass spectrometry, optical spectrometry, and nuclear magnetic resonance (NMR) technologies. Increasing demand for precision diagnostics in healthcare and pharmaceuticals is a key trend, as spectrometry plays a crucial role in biomarker detection and drug development. Rising investments in chemical and material industries are further boosting market growth, particularly in material identification and forensic applications. Technological innovations, such as AI-driven data analysis and miniaturized portable spectrometers, are expanding adoption across various sectors.
The rise of personalized healthcare is fueling innovations in biomedical spectrometry, with applications ranging from non-invasive diagnostics to therapeutic monitoring. The novel spectrometry industry is developing cutting-edge solutions for real-time blood analysis, cancer screening, and metabolic profiling. Technologies such as surface-enhanced Raman spectroscopy (SERS) and infrared spectroscopy are enabling early disease detection with minimal sample preparation. The shift toward point-of-care diagnostics is increasing the demand for portable spectrometry devices that offer rapid and accurate results. As precision medicine continues to gain traction, novel spectrometry solutions will play a vital role in advancing healthcare outcomes.
Quantum-enhanced spectrometry is emerging as a transformative technology within the novel spectrometry industry, offering unprecedented sensitivity and resolution. Techniques such as quantum entanglement-based spectroscopy and single-photon detection are revolutionizing molecular and atomic analysis. These advancements are particularly beneficial for biomedical applications, where ultra-sensitive detection of biomarkers can lead to early disease diagnosis. The integration of quantum computing with spectrometry is further enhancing data processing capabilities, enabling new breakthroughs in material science. As research in quantum optics progresses, the commercial adoption of quantum spectrometry is expected to accelerate in the coming years.
The demand for portable and handheld spectrometry devices is increasing, leading to significant advancements in miniaturization within the novel spectrometry industry. Compact spectrometers are being developed for field applications such as agricultural testing, counterfeit detection, and point-of-care diagnostics. These devices offer real-time analysis with high sensitivity, enabling on-the-spot decision-making without the need for extensive laboratory infrastructure. The development of smartphone-integrated spectrometers is further expanding the accessibility of spectrometry technology. As a result, industries that require rapid and cost-effective material analysis are driving the adoption of miniaturized spectrometry solutions.
The novel spectrometry industry is playing a crucial role in drug discovery and pharmaceutical research, where precision and sensitivity are essential. Advanced mass spectrometry and Raman spectrometry techniques are being adopted to accelerate biomarker identification, protein analysis, and small molecule screening. The increasing focus on personalized medicine and biologics is driving the need for novel spectrometry solutions capable of handling complex biological samples. Regulatory agencies are also encouraging the adoption of advanced spectrometry technologies for quality control and compliance. Consequently, pharmaceutical companies are partnering with spectrometry providers to enhance drug development pipelines.
Global Novel Spectrometry Market Report Segmentation
This report forecasts revenue growth at the regional and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the novel spectrometry market report based on spectrometry type, application, end use, and region:
- Spectrometry Type Outlook (Revenue, USD Million, 2018 - 2030)
- Mass Spectrometry (MS)
- Optical Spectrometry
- Nuclear Magnetic Resonance (NMR)
- X-ray Spectrometry
- Others
- Application Outlook (Revenue, USD Million, 2018 - 2030)
- Analytical Testing & Diagnostics
- Quality Control & Assurance
- Material Identification
- Environmental Monitoring
- Food Safety & Inspection
- Others
- End Use Outlook (Revenue, USD Million, 2018 - 2030)
- Healthcare & Pharmaceuticals
- Agriculture
- Government & Academic Institutions
- Chemical & Material Industries
- Food & Beverage Industry
- Energy & Utilities
- Others
- Regional Outlook (Revenue, USD Million, 2018 - 2030)
- North America
- Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Latin America
- Middle East and Africa
- Saudi Arabia
- UAE
- South Africa
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation and Scope
- 1.2. Market Definitions
- 1.2.1. Information analysis
- 1.2.2. Market formulation & data visualization
- 1.2.3. Data validation & publishing
- 1.3. Research Scope and Assumptions
- 1.3.1. List of Data Sources
Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Outlook
- 2.3. Competitive Insights
Chapter 3. Novel Spectrometry Market Variables, Trends, & Scope
- 3.1. Market Lineage Outlook
- 3.2. Market Dynamics
- 3.2.1. Market Driver Analysis
- 3.2.2. Market Restraint Analysis
- 3.2.3. Industry Challenge
- 3.3. Novel Spectrometry Market Analysis Tools
- 3.3.1. Industry Analysis - Porter's
- 3.3.1.1. Bargaining power of the suppliers
- 3.3.1.2. Bargaining power of the buyers
- 3.3.1.3. Threats of substitution
- 3.3.1.4. Threats from new entrants
- 3.3.1.5. Competitive rivalry
- 3.3.2. PESTEL Analysis
- 3.3.2.1. Political landscape
- 3.3.2.2. Economic and social landscape
- 3.3.2.3. Technological landscape
Chapter 4. Novel Spectrometry Market: Spectrometry Type Estimates & Trend Analysis
- 4.1. Segment Dashboard
- 4.2. Novel Spectrometry Market: Spectrometry Type Movement Analysis, USD Million, 2024 & 2030
- 4.3. Mass Spectrometry (MS)
- 4.3.1. Mass Spectrometry (MS) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.4. Optical Spectrometry
- 4.4.1. Optical Spectrometry Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.5. Nuclear Magnetic Resonance (NMR)
- 4.5.1. Nuclear Magnetic Resonance (NMR) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.6. X-ray Spectrometry
- 4.6.1. X-ray Spectrometry Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.7. Others
- 4.7.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 5. Novel Spectrometry Market: Application Estimates & Trend Analysis
- 5.1. Segment Dashboard
- 5.2. Novel Spectrometry Market: Application Movement Analysis, USD Million, 2024 & 2030
- 5.3. Analytical Testing & Diagnostics
- 5.3.1. Analytical Testing & Diagnostics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.4. Quality Control & Assurance
- 5.4.1. Quality Control & Assurance Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.5. Material Identification
- 5.5.1. Material Identification Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.6. Environmental Monitoring
- 5.6.1. Environmental Monitoring Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.7. Food Safety & Inspection
- 5.7.1. Food Safety & Inspection Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.8. Others
- 5.8.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 6. Novel Spectrometry Market: End Use Estimates & Trend Analysis
- 6.1. Segment Dashboard
- 6.2. Novel Spectrometry Market: End Use Movement Analysis, USD Million, 2024 & 2030
- 6.3. Healthcare & Pharmaceuticals
- 6.3.1. Healthcare & Pharmaceuticals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.4. Agriculture
- 6.4.1. Agriculture Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.5. Government & Academic Institutions
- 6.5.1. Government & Academic Institutions Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.6. Chemical & Material Industries
- 6.6.1. Chemical & Material Industries Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.7. Food & Beverage Industry
- 6.7.1. Food & Beverage Industry Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.8. Energy & Utilities
- 6.8.1. Energy & Utilities Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.9. Others
- 6.9.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 7. Novel Spectrometry Market: Regional Estimates & Trend Analysis
- 7.1. Novel Spectrometry Market Share, By Region, 2024 & 2030 USD Million
- 7.2. North America
- 7.2.1. North America Novel Spectrometry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.2.2. U.S.
- 7.2.2.1. U.S. Novel Spectrometry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.2.3. Canada
- 7.2.3.1. Canada Novel Spectrometry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.2.4. Mexico
- 7.2.4.1. Mexico Novel Spectrometry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.3. Europe
- 7.3.1. Europe Novel Spectrometry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.3.2. U.K.
- 7.3.2.1. U.K. Novel Spectrometry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.3.3. Germany
- 7.3.3.1. Germany Novel Spectrometry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.3.4. France
- 7.3.4.1. France Novel Spectrometry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.4. Asia Pacific
- 7.4.1. Asia Pacific Novel Spectrometry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.4.2. China
- 7.4.2.1. China Novel Spectrometry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.4.3. Japan
- 7.4.3.1. Japan Novel Spectrometry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.4.4. India
- 7.4.4.1. India Novel Spectrometry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.4.5. South Korea
- 7.4.5.1. South Korea Novel Spectrometry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.4.6. Australia
- 7.4.6.1. Australia Novel Spectrometry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.5. Latin America
- 7.5.1. Latin America Novel Spectrometry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.5.2. Brazil
- 7.5.2.1. Brazil Novel Spectrometry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.6. Middle East and Africa
- 7.6.1. Middle East and Africa Novel Spectrometry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.6.2. Saudi Arabia
- 7.6.2.1. Saudi Arabia Novel Spectrometry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.6.3. UAE
- 7.6.3.1. UAE Novel Spectrometry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.6.4. South Africa
- 7.6.4.1. South Africa Novel Spectrometry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 8. Competitive Landscape
- 8.1. Company Categorization
- 8.2. Company Market Positioning
- 8.3. Company Heat Map Analysis
- 8.4. Company Profiles/Listing
- 8.4.1. Rigaku Group
- 8.4.1.1. Participant's Overview
- 8.4.1.2. Financial Performance
- 8.4.1.3. Product Benchmarking
- 8.4.1.4. Strategic Initiatives
- 8.4.2. Thermo Fisher Scientific
- 8.4.2.1. Participant's Overview
- 8.4.2.2. Financial Performance
- 8.4.2.3. Product Benchmarking
- 8.4.2.4. Strategic Initiatives
- 8.4.3. PerkinElmer AES
- 8.4.3.1. Participant's Overview
- 8.4.3.2. Financial Performance
- 8.4.3.3. Product Benchmarking
- 8.4.3.4. Strategic Initiatives
- 8.4.4. LightMachinery, Inc.
- 8.4.4.1. Participant's Overview
- 8.4.4.2. Financial Performance
- 8.4.4.3. Product Benchmarking
- 8.4.4.4. Strategic Initiatives
- 8.4.5. Bruker Corporation
- 8.4.5.1. Participant's Overview
- 8.4.5.2. Financial Performance
- 8.4.5.3. Product Benchmarking
- 8.4.5.4. Strategic Initiatives
- 8.4.6. Keit Industrial Analytics
- 8.4.6.1. Participant's Overview
- 8.4.6.2. Financial Performance
- 8.4.6.3. Product Benchmarking
- 8.4.6.4. Strategic Initiatives
- 8.4.7. Agilent Technologies, Inc.
- 8.4.7.1. Participant's Overview
- 8.4.7.2. Financial Performance
- 8.4.7.3. Product Benchmarking
- 8.4.7.4. Strategic Initiatives
- 8.4.8. SPECTRO Analytical Instruments GmbH
- 8.4.8.1. Participant's Overview
- 8.4.8.2. Financial Performance
- 8.4.8.3. Product Benchmarking
- 8.4.8.4. Strategic Initiatives
- 8.4.9. DetectaChem
- 8.4.9.1. Participant's Overview
- 8.4.9.2. Financial Performance
- 8.4.9.3. Product Benchmarking
- 8.4.9.4. Strategic Initiatives
- 8.4.10. Advion, Inc.
- 8.4.10.1. Participant's Overview
- 8.4.10.2. Financial Performance
- 8.4.10.3. Product Benchmarking
- 8.4.10.4. Strategic Initiatives